DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment

DPPC-coated lipid nanoparticles as an inhalable carrier for accumulation of resveratrol in the pulmonary vasculature, a new strategy for pulmonary arterial hypertension treatment

In this study, we investigated the feasibility of dipalmitoylphosphatidylcholine-coated lipid nanoparticles (DPPC-LNs) as a carrier for preferential accumulation into lungs of Resveratrol (Res), a potentially promising drug for the treatment of pulmonary arterial hypertension (PAH). Res-loaded DPPC-...

Full description

Bibliographic Details
Main Authors: Zerong Li, Wenmei Qiao, Chenghao Wang, Heqiao Wang, Mengchao Ma, Xinyu Han, Jingling Tang
Format: Article
Language:English
Published: Taylor & Francis Group 2020-01-01
Series:Drug Delivery
Subjects:
lipid nanoparticles
pulmonary arterial hypertension
pulmonary delivery
pulmonary surfactant
resveratrol
Online Access:http://dx.doi.org/10.1080/10717544.2020.1760962

Internet

http://dx.doi.org/10.1080/10717544.2020.1760962

Similar Items